Clinical Trials
30 trialsTailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Fred Hutchinson Cancer Center
TIMED
UNC Lineberger Comprehensive Cancer Center
PAIR-LUNG
Universidade Nova de Lisboa
Evaluate BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer
SystImmune Inc.
APPAREL
University Hospital Schleswig-Holstein
Testing the SurVaxM Vaccine for Lung Cancer Prevention
National Cancer Institute (NCI)
ALINEAR
AstraZeneca
DIASTAG
AstraZeneca
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
City of Hope Medical Center
ANASTASIA
AstraZeneca
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Fred Hutchinson Cancer Center
CALMS-1
University of Texas Southwestern Medical Center
LungSMART
University of Utah
LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol B
Massachusetts General Hospital
ICARE-LCS
VA Office of Research and Development
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Fred Hutchinson Cancer Center
REVIVE
University of Chicago
Real-Time IGRT
University of Sydney
PVD-Lungs
International Agency for Research on Cancer
Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
Boehringer Ingelheim
Construction and Preliminary Evaluation of Dyadic Acceptance and Commitment Therapy for Couples With Fear of Lung Cancer Recurrence
Fujian Medical University
Clinical Study on the Effects of Pulmonary Vessels on Cryoablation and Preventive Embolization Strategies
First Hospital of China Medical University
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
Shanghai Pulmonary Hospital, Shanghai, China
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SUNRISE
AdventHealth Translational Research Institute
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
ECHO
AstraZeneca
SPARC
University of Utah
5T4 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
ILST
All India Institute of Medical Sciences